Cardiovascular Infection
Prosthetic Valve Endocarditis
Prosthetic valve endocarditis requires early culture-directed evaluation, transesophageal echocardiography, and selective CT or FDG-PET/CT to detect occult paravalvular infection and define urgency for valve surgery.
First hours
Stabilize, culture, and classify before antimicrobial exposure
Treat suspected PVE as a potentially destructive infection requiring parallel diagnostic and surgical assessment.
Assess immediately for prosthetic dysfunction causing acute heart failure or cardiogenic shock, conduction disturbance suggesting annular extension, systemic embolic disease, and persistent bacteremia. Valve dysfunction causing refractory heart failure or cardiogenic shock, new heart block, annular or aortic abscess, and penetrating lesions are high-risk features that warrant urgent endocarditis-team and surgical involvement.jaccjaccDiagnosis and Management of Infective Endocarditis in People Who Inject Drugs: JACC State-of-the-Art Review
Obtain blood cultures before starting antibiotics whenever clinical stability permits. Diagnostic classification should use the Duke-ISCVID framework, which integrates clinical findings, microbiology, echocardiography, cardiac CT, FDG-PET/CT, molecular microbiology, and intraoperative evidence.jacc+1jacc2020 ACC/AHA Guideline for the Management of Patients ...Oxford Academic2023 Duke-International Society for Cardiovascular Infectious Diseases Criteria for Infective Endocarditis: Updating the Modified Duke Criteria | Clinical Infectious Diseases | Oxford Academic
Do not exclude PVE after a nondiagnostic initial echocardiogram. Compared with native-valve endocarditis, PVE has fewer visible vegetations—particularly with mechanical valves—but more annular abscesses and paravalvular complications; serial imaging comparison therefore changes diagnostic confidence and operative planning.jaccjacc2020 ACC/AHA Guideline for the Management of Patients ...
Obtain infectious diseases and valve/endocarditis multidisciplinary input at presentation; ACC/AHA guidance identifies infectious diseases expertise as a core component of endocarditis management.jaccjacc2020 ACC/AHA Guideline for the Management of Patients ...
Reassess with repeat TEE and/or TTE when clinical signs change or when the patient is at high risk for complications.jaccjacc2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
Diagnostic branch
Use multimodality imaging when TEE does not resolve prosthetic-valve infection
Imaging should answer two separate questions: is the prosthesis infected, and has infection extended beyond the valve?
Perform early TEE in suspected PVE because auscultation may be unrevealing and TTE can miss prosthetic-valve lesions. TEE remains central, but sensitivity is lower in PVE than in native-valve infection; compare serial studies rather than treating one negative examination as definitive.jaccjacc2020 ACC/AHA Guideline for the Management of Patients ...
Escalate to cardiac CT when suspected paravalvular infection cannot be anatomically delineated by echocardiography. CT can establish pseudoaneurysm, intracardiac fistula, valve perforation or aneurysm, and other paravalvular lesions that affect the feasibility and extent of surgery.AHA JournalsAHA JournalsMultimodality Imaging in Infective Endocarditis
Use FDG-PET/CT as an adjunct when PVE remains possible after conventional assessment, particularly with complex implants. In a prospective cohort of suspected PVE, abnormal cardiac uptake had 73.6% sensitivity and 75% specificity for definite PVE; the 2023 Duke-ISCVID criteria incorporate FDG-PET/CT and cardiac CT among diagnostic modalities.ScienceDirect+1ScienceDirectComparison Between ESC and Duke Criteria for the Diagnosis of Prosthetic Valve Infective Endocarditis - ScienceDirectOxford Academic2023 Duke-International Society for Cardiovascular Infectious Diseases Criteria for Infective Endocarditis: Updating the Modified Duke Criteria | Clinical Infectious Diseases | Oxford Academic
Microbiology branch
Direct antimicrobial strategy by organism, resistance, and prosthetic material
Culture results and susceptibility testing should drive definitive therapy and the urgency of source control.
Staphylococci are the dominant PVE pathogens, accounting for approximately 40% of contemporary cases, with S. aureus the most common organism. Healthcare-associated infection is common in PVE and should heighten concern for S. aureus and resistant organisms.PubMedPubMedContemporary Features and Management of Endocarditis - PMC
For MRSA or methicillin-resistant coagulase-negative staphylococcal PVE, published treatment recommendations have used vancomycin with rifampin plus an aminoglycoside, but the evidence base is largely expert opinion, animal data, and retrospective experience rather than large PVE trials.acpjournals+2acpjournalsStaphylococcus epidermidis Causing Prosthetic Valve ...acpjournalsCombination Antimicrobial Therapy for Staphylococcus ...PubMedMethicillin-Resistant Staphylococcus aureus Prosthetic Valve Endocarditis: Pathophysiology, Epidemiology, Clinical Presentation, Diagnosis, and Management - PMC Avoid presenting adjunctive rifampin or aminoglycoside therapy as risk-free: nephrotoxicity, drug interactions, and resistance selection require organism-specific infectious diseases oversight.
Complicated native-valve infection, PVE, and endocarditis complicated by osteomyelitis are generally treated for 6 weeks in the cited comparative-regimen review.CochraneCochraneA comparison of different antibiotic regimens for the treatment of ... If blood cultures remain positive or the patient develops worsening heart failure, embolic events, conduction abnormalities, or enlarging lesions despite therapy, treat this as failure of medical control and re-evaluate urgently for surgery.jacc+1jaccDiagnosis and Management of Infective Endocarditis in People Who Inject Drugs: JACC State-of-the-Art ReviewPubMedNative valve, prosthetic valve, and cardiac device-related infective endocarditis: A review and update on current innovative diagnostic and therapeutic strategies
| Finding | Interpretation | Management implication |
|---|---|---|
| S. aureus or coagulase-negative staphylococcal PVE | Staphylococci cause about 40% of PVE; S. aureus is the most common pathogen.PubMedPubMedContemporary Features and Management of Endocarditis - PMC | Require susceptibility-directed intravenous therapy and early assessment for destructive infection or operative source control. |
| MRSA PVE | Mortality estimates range from 40% to 80%; historical recommendations use vancomycin with rifampin and an aminoglycoside.acpjournals+1acpjournalsStaphylococcus epidermidis Causing Prosthetic Valve ...PubMedMethicillin-Resistant Staphylococcus aureus Prosthetic Valve Endocarditis: Pathophysiology, Epidemiology, Clinical Presentation, Diagnosis, and Management - PMC | Use infectious diseases-directed therapy; assess renal toxicity and drug interactions while pursuing source control. |
| Fungal or multiresistant organism | These pathogens are associated with guideline-level surgical indications.jaccjaccDiagnosis and Management of Infective Endocarditis in People Who Inject Drugs: JACC State-of-the-Art Review | Obtain urgent cardiac surgical assessment rather than relying on medical therapy alone. |
| PVE or other complicated endocarditis | A 6-week treatment duration is reported for PVE and complicated infection.CochraneCochraneA comparison of different antibiotic regimens for the treatment of ... | Plan prolonged parenteral therapy with serial microbiologic and complication assessment. |
Definitive control
Refer early for surgery when infection causes hemodynamic compromise, invasive extension, or uncontrolled sepsis
The operative decision is driven by heart failure, local invasion, failure of antimicrobial control, and embolic risk—not vegetation alone.
Surgery is indicated for prosthetic-valve dysfunction causing heart failure, severe acute regurgitation, obstruction, or fistula with refractory heart failure, cardiogenic shock, or poor hemodynamic tolerance. These are time-sensitive indications because waiting for antimicrobial completion can permit irreversible hemodynamic deterioration.jaccjaccDiagnosis and Management of Infective Endocarditis in People Who Inject Drugs: JACC State-of-the-Art Review
Treat abscess, false aneurysm, fistula, enlarging vegetation, new conduction disease, or other locally uncontrolled infection as a surgical problem. PVE has a higher burden of annular abscess and paravalvular complications than native-valve infection, making CT and serial TEE useful for defining invasive anatomy.jacc+2jaccDiagnosis and Management of Infective Endocarditis in People Who Inject Drugs: JACC State-of-the-Art Reviewjacc2020 ACC/AHA Guideline for the Management of Patients ...AHA JournalsMultimodality Imaging in Infective Endocarditis
Persistent sepsis, acute renal failure, embolic events or high embolic risk, mobile or large lesions greater than 10 mm, and fungal or multiresistant infection are reported operative triggers in PVE reviews and guideline comparisons.jacc+1jaccDiagnosis and Management of Infective Endocarditis in People Who Inject Drugs: JACC State-of-the-Art ReviewPubMedNative valve, prosthetic valve, and cardiac device-related infective endocarditis: A review and update on current innovative diagnostic and therapeutic strategies A multidisciplinary discussion should incorporate neurologic status, hemodynamic stability, prosthesis type, anatomic reconstruction requirements, and likelihood of durable infection control.
In patients with injection drug use, do not withhold surgery solely because of substance use; cited guidance supports surgery for failed medical therapy, septic pulmonary emboli, and large vegetations, while incorporating addiction treatment and recurrence risk into longitudinal planning.jaccjaccDiagnosis and Management of Infective Endocarditis in People Who Inject Drugs: JACC State-of-the-Art Review
Expect high perioperative risk in complex PVE: reported adverse postoperative outcomes include embolization and acute renal failure at 21%, new dialysis at 20%, stroke at 13% to 19%, and reoperation for bleeding at 12% to 14%.PubMedPubMedNative valve, prosthetic valve, and cardiac device-related infective endocarditis: A review and update on current innovative diagnostic and therapeutic strategies
Reassessment
Monitor for microbiologic clearance and delayed structural complications
PVE management remains dynamic until infection control and prosthetic function are both established.
Repeat TEE and/or TTE when symptoms or signs change and in patients at high risk for complications. Compare studies for enlarging vegetation, worsening regurgitation or obstruction, new dehiscence, and newly visible paravalvular extension; serial imaging has particular value in PVE because the initial TEE may be falsely reassuring.jacc+1jacc2020 ACC/AHA Guideline for the Management of Patients ...jacc2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
Follow the patient for new heart failure, cardiogenic shock, atrioventricular conduction disease, embolic events, and persistent sepsis, each of which changes the surgical urgency. Contemporary PVE mortality is estimated at 22% to 40%, supporting close inpatient reassessment rather than a static antibiotic-only plan.jacc+1jaccDiagnosis and Management of Infective Endocarditis in People Who Inject Drugs: JACC State-of-the-Art ReviewPubMedContemporary Features and Management of Endocarditis - PMC
If the patient has a prosthetic valve and infective endocarditis with neurologic complications, one CHEST guideline suggests holding vitamin K antagonist therapy until the patient is stabilized without neurologic complications. Anticoagulation decisions require individualized coordination among cardiology, neurology, infectious diseases, and cardiac surgery because thrombotic and hemorrhagic risks can compete.journal chestnetjournal chestnetAntithrombotic and Thrombolytic Therapy for Valvular Disease
References
- Infective endocarditis — www.thelancet.com · www.thelancet.com
- Diagnosis and Management of Infective Endocarditis in People Who Inject Drugs: JACC State-of-the-Art Review — www.jacc.org · www.jacc.org
- 2020 ACC/AHA Guideline for the Management of Patients ... — www.jacc.org · www.jacc.org
- ACC/AHA Versus ESC Guidelines on Prosthetic Heart Valve Management: JACC Guideline Comparison — www.jacc.org · www.jacc.org
- 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines — www.jacc.org · www.jacc.org
- Multimodality Imaging in Infective Endocarditis — www.ahajournals.org · www.ahajournals.org
- Staphylococcus epidermidis Causing Prosthetic Valve ... — www.acpjournals.org · www.acpjournals.org
- Combination Antimicrobial Therapy for Staphylococcus ... — www.acpjournals.org · www.acpjournals.org
- [18F]FDG-PET CT for the evaluation of native valve endocarditis - ScienceDirect — www.sciencedirect.com · www.sciencedirect.com
- Comparison Between ESC and Duke Criteria for the Diagnosis of Prosthetic Valve Infective Endocarditis - ScienceDirect — www.sciencedirect.com · www.sciencedirect.com
- Correlating cardiac F-18 FDG PET/CT results with intra-operative findings in infectious endocarditis - ScienceDirect — www.sciencedirect.com · www.sciencedirect.com
- 18F-FDG PET/CT improves diagnostic certainty in native and prosthetic valve Infective Endocarditis over the modified Duke Criteria - ScienceDirect — www.sciencedirect.com · www.sciencedirect.com
- 2023 Duke-International Society for Cardiovascular Infectious Diseases Criteria for Infective Endocarditis: Updating the Modified Duke Criteria | Clinical Infectious Diseases | Oxford Academic — academic.oup.com · academic.oup.com
- Infective Endocarditis : Advanced Emergency Nursing Journal — journals.lww.com · journals.lww.com
- New agents for Staphylococcus aureus endocarditis — journals.lww.com · journals.lww.com
- Abstracts : Journal of Clinical Infectious Disease Society — journals.lww.com · journals.lww.com
- Abstracts at CIDSCON 2024 : Journal of Clinical Infectious ... — journals.lww.com · journals.lww.com
- Clinical Guidance for Acute Rheumatic Fever | Group A Strep | CDC — www.cdc.gov · www.cdc.gov
- A comparison of different antibiotic regimens for the treatment of ... — www.cochranelibrary.com · www.cochranelibrary.com
- Antithrombotic and Thrombolytic Therapy for Valvular Disease — journal.chestnet.org · journal.chestnet.org
- Safety and Effectiveness of Edwards Lifesciences SAPIEN XTTM ... — cdn.clinicaltrials.gov · cdn.clinicaltrials.gov
- Native valve, prosthetic valve, and cardiac device-related infective endocarditis: A review and update on current innovative diagnostic and therapeutic strategies — pmc.ncbi.nlm.nih.gov · pmc.ncbi.nlm.nih.gov
- Methicillin-Resistant Staphylococcus aureus Prosthetic Valve Endocarditis: Pathophysiology, Epidemiology, Clinical Presentation, Diagnosis, and Management - PMC — pmc.ncbi.nlm.nih.gov · pmc.ncbi.nlm.nih.gov
- Contemporary Features and Management of Endocarditis - PMC — pmc.ncbi.nlm.nih.gov · pmc.ncbi.nlm.nih.gov